Joanne Edwards - Concepedia

Author

Joanne Edwards

Also Known As

Amerdip Birring, Campbell Roxburgh, Colin W Steele, Edwards, Jim, Edwards, Joanne, Edwards, Judy M, J Edwards, J J Edwards, J. Edwards, J. J. Edwards

698

Publications

14.6K

Citations

H-Index

107

Concepts

All Affiliations

University of Glasgow Glasgow Royal Infirmary Western Infirmary Cancer Research UK Scotland Institute Queen Elizabeth University Hospital

About

Joanne Edwards is an author at University of Glasgow specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	46	3.6K
2	Natural Sciences	4	4	214
3	Engineering	3	3	319
4	Health Sciences	1	1	14
5	Public Health	1	1	17

Joanne Edwards

152

Publications

11K

Citations

H-Index

Page 1

	Year	Citations
A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion–Resistant Growth Zhiyong Guo, Xi Yang, Feng Sun, Cancer Research	2009	870
The Histone Deacetylase SIRT6 Is a Tumor Suppressor that Controls Cancer Metabolism Carlos Sebastián, Bernadette Zwaans, Dafne M. Silberman, Cell Histone ModificationsEpigenetic ChangeHistone Deacetylase Sirt6Cancer BiologyEpigenetics	2012	651
Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer Rong Hu, Changxue Lu, Elahe A. Mostaghel, Cancer Research	2012	583
Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer Joanne Edwards, N. Sarath Krishna, Ken Grigor, British Journal of Cancer	2003	426
Mannose impairs tumour growth and enhances chemotherapy Pablo Sierra Gonzalez, James O’Prey, Simone Cardaci, Nature Tumor BiologyMannose ImpairsMalignant DiseaseMedicinePathology	2018	410
Observer variation in immunohistochemical analysis of protein expression, time for a change? Thomas Kirkegaard, Joanne Edwards, Sian Tovey, Histopathology	2006	235
Gene amplifications associated with the development of hormone-resistant prostate cancer. Joanne Edwards, N. Sarath Krishna, Caroline Witton, PubMed EngineeringGeneticsHormone ResistanceTumor BiologyGenitourinary Cancer	2003	211
MCL-1 is a prognostic indicator and drug target in breast cancer Kirsteen J. Campbell, Sandeep Dhayade, Nicola Ferrari, Cell Death and Disease	2018	196
High Expression of Sphingosine 1-Phosphate Receptors, S1P1 and S1P3, Sphingosine Kinase 1, and Extracellular Signal-Regulated Kinase-1/2 Is Associated with Development of Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Patients Carol Watson, Jaclyn S. Long, Clare Orange, American Journal Of Pathology Breast OncologyTamoxifen ResistanceSphingosine Kinase 1Hormonal ReceptorReceptor Tyrosine Kinase	2010	169
Next-generation Sequencing of Advanced Prostate Cancer Treated with Androgen-deprivation Therapy Prabhakar Rajan, Ian Sudbery, M. Eugenia M. Villasevil, European Urology	2013	159

Page 1